Tycoon2FA has become a leading phishing-as-a-service (PhaaS) platforms, enabling campaigns that reach over 500,000 organizations monthly, prompting Microsoft’s Digital Crimes Unit (DCU) to work with ...
Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 million Q4 2025 operating profit of €10 million and cash flow from operating activities of €73 million TransCon ® CNP under ...
The Lamb Weston board of directors has appointed Jan Craps executive chair, effective February 6, 2026. Jan brings deep international experience to the newly created role, including more than 20 years ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced a significant milestone for its flagship Oncotype DX Breast Recurrence Score®test: ...
OLD GREENWICH, Conn.--(BUSINESS WIRE)-- Ellington Financial Inc. (EFC) (the “Company”) announced today that it has priced an underwritten public offering of 8,775,000 shares of its common stock for ...
Lamb Weston Holdings, Inc. (NYSE: LW) announced today its results for the second quarter of fiscal 2026 and updated its full year financial targets for fiscal 2026. Summary of Second Quarter FY 2026 ...
SUMMIT, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced that the Company’s Board of Directors has authorized the initiation of a ...
Ready to unlock your full math potential? 🎓Subscribe for clear, fun, and easy-to-follow lessons that will boost your skills, build your confidence, and help you master math like a genius—one step at ...
AVENTURA, Fla.--(BUSINESS WIRE)--Immersion Corporation (“Immersion”, the “Company”, “we”, “us” or “our”) (Nasdaq: IMMR), a leading provider of ...
Iran is ready to sign a nuclear deal with certain conditions with President Donald Trump in exchange for lifting economic sanctions, a top adviser to Iran’s supreme leader told NBC News on Wednesday.
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results